Lymphotoxins

The Cytokine Handbook

Volumn , Issue , 2003, Pages 825-835

  Granger, Steve W ^a   Ware, Carl F ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868144523     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012689663-3/50038-7     Document Type: Chapter

References (103)

1. Alimzhanov M.B., Kuprash D.V., Kosco-Vilbois M.H., et al. Abnormal development of secondary lymphoid tissues in lymphotoxin β-deficient mice. Proc. Natl Acad. Sci. USA 1997, 94:9302-9307.
2. Andrews J.S., Berger A.E., Ware C.F. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma (published erratum appears in J. Immunol. (1990) 144, 4906). J. Immunol. 1990, 144:2582-2591.
3. Androlewicz M.J., Browning J.L., Ware C.F. Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated human T cell hybridoma. J. Biol. Chem. 1992, 267:2542-2547.
4. Ansel K.M., Ngo V.N., Hyman P.L., et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 2000, 406:309-314.
5. Ansel K.M., Harris R.B., Cyster J.G. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 2002, 16:67-76.
6. Banks T.A., Rouse B.T., Kerley M.K., et al. Lymphotoxin-α-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J. Immunol. 1995, 155:1685-1693.
7. Banner D.W., D'Arcy A., Janes W., et al. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 1993, 73:431-445.
8. Benedict C.A., Banks T.A., Senderowicz L., et al. Lymphotoxins and cytomegalovirus cooperatively induce interferon-β, establishing host-virus détente. Immunity 2001, 15:617-626.
9. Benedict C.A., Ware C.F. Virus targeting of the TNF superfamily. Virology 2001, 289:1-5.
10. Berger D.P., Naniche D., Crowley M.T., et al. Lymphotoxin-β-deficient mice show defective antiviral immunity. Virology 1999, 260:136-147.
11. Bodmer J.L., Schneider P., Tschopp J. The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 2002, 27:19-26.
12. Browning J., Ribolini A. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines. J. Immunol. 1989, 143:1859-1867.
13. Browning J.L., French L.E. Visualization of lymphotoxin-beta and lymphotoxin-beta receptor expression in mouse embryos. J. Immunol. 2002, 168:5079-5087.
14. Browning J.L., Ngam-ek A., Lawton P., et al. Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 1993, 72:847-856.
15. Browning J.L., Sizing I.D., Lawton P., et al. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes. J. Immunol. 1997, 159:3288-3298.
16. Cha S.S., Kim M.S., Choi Y.H., et al. 2.8 A resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity. Immunity 1999, 11:253-261.
17. Crowe P.D., VanArsdale T.L., Goodwin R.G., Ware C.F. Specific induction of 80-kDa tumor necrosis factor receptor shedding in T lymphocytes involves the cytoplasmic domain and phosphorylation. J. Immunol. 1993, 151:6882-6890.
18. Crowe P.D., VanArsdale T.L., Walter B.N. A lymphotoxin-beta-specific receptor. Science 1994, 264:707-710.
19. Crowe P.D., Walter B.N., Mohler K.M., et al. A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J. Exp. Med. 1995, 181:1205-1210.
20. Cyster J.G. Chemokines and cell migration in secondary lymphoid organs. Science 1999, 286:2098-2102.
21. Cyster J.G. Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. J. Exp. Med. 1999, 189:447-450.
22. Cyster J.G., Ansel K.M., Reif K., et al. Follicular stromal cells and lymphocyte homing to follicles. Immunol. Rev. 2000, 176:181-193.
23. Dejardin E., Droin N.M., Delhase M., et al. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappa B pathways. Immunity 2002, 17:525.
24. DeTogni P., Goellner J., Ruddle N.H., et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994, 264:703-706.
25. Eck M.J., Sprang S.R. The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding. J. Biol. Chem. 1989, 264:17595-17605.
26. Eck M.J., Ultsch M., Rinderknecht E., et al. The structure of human lymphotoxin (tumor necrosis factor-β) at 1.9-A resolution. J. Biol. Chem. 1992, 267:2119-2122.
27. Elewaut D., Brossay L., Santee S.M., et al. Membrane lymphotoxin is required early in ontogeny for development of different subpopulations of NK T cells. J. Immunol. 2000, 165:671-679.
28. Engelmann H., Holtmann H., Brakebusch C., et al. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J. Biol. Chem. 1990, 265:14497-14504.
29. Ettinger R., Browning J.L., Michie S.A., et al. Disrupted splenic architecture, but normal lymphnode development in mice expressing a soluble lymphotoxin-β receptor-IgG1 chimeric fusion protein. Proc. Natl Acad. Sci. USA 1996, 93:13102-13107.
30. Ettinger R., Mebius R., Browning J.L., et al. Effects of tumor necrosis factor and lymphotoxin on peripheral lymphoid tissue development. Int. Immunol. 1998, 10:727-741.
31. Force W.R., Cheung T.C., Ware C.F. Dominant negative mutants of TRAF3 reveal an important role for the coiled coil domains in cell death signaling by the lymphotoxin-β receptor (LTβR). J. Biol. Chem. 1997, 272:30835-30840.
32. Force W.R., Glass A.A., Benedict C.A., et al. Discrete signaling regions in the lymphotoxin-β receptor for TRAF binding, subcellular localization and activation of cell death and NFβB pathways. J. Biol. Chem. 2000, 275:11121-11129.
33. Fu Y.-X., Chaplin D. Development and maturation of secondary lymphoid tissues. Annu. Rev. Immunol. 1999, 17:399-433.
34. Fu Y.-X., Huang G., Matsumoto M., et al. Independent signals regulate development of primary and secondary follicle structure in spleen and mesenteric lymph node. Proc. Natl Acad. Sci. USA 1997, 94:5739-5743.
35. Futterer A., Mink K., Luz A., et al. The lymphotoxin beta receptor controls organigenesis and affinity maturation in peripheral lymphoid tissues. Immunity 1998, 9:59-70.
36. Gehr G., Gentz R., Brockhaus M., et al. Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation. J. Immunol. 1992, 149:911-917.
37. Gramaglia I., Mauri D.N., Miner K.T., et al. Lymphotoxin ab is expressed on recently activated naïve and Th1-like CD4 cells, but is downregulated by IL-4 during TH2 differentiation. J. Immunol. 1998, 162:1333-1338.
38. Granger G.A., Williams T.W. Lymphocyte cytotoxicity in vitro: activation and release of a cytotoxic factor. Nature 1968, 218:1253-1254.
39. Granger S.W., Butrovich K.D., Houshmand P., et al. Genomic characterization of LIGHT reveals linkage to an immune response locus on chromosome 19p13.3 and distinct isoforms generated by alternate splicing or proteolysis. J. Immunol. 2001, 167:5122-5128.
40. Gray P., Aggarwal B., Benton C., et al. Cloning and expression of the cDNA for human lymphotoxin: a lymphokine with tumor necrosis activity. Nature 1984, 312:721-724.
41. Harmsen A., Kusser K., Hartson L., et al. Cutting edge: organogenesis of nasal-associated lymphoid tissue (NALT) occurs independently of lymphotoxin-alpha (LT alpha) and retinoic acid receptor-related orphan receptor-gamma, but the organization of NALT is LT alpha dependent. J. Immunol. 2002, 168:968-990.
42. Hjelmstrom P. Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J. Leukoc. Biol. 2001, 69:331-339.
43. Hjelmstrom P., Fjell J., Nakagawa T., et al. Lymphoid tissue homing chemokines are expressed in chronic inflammation. Am. J. Pathol. 2000, 156:1133-1138.
44. Honda K., Nakano H., Yoshida H., et al. Molecular basis for hematopoietic/mesenchymal interaction during initiation of Peyer's patch organogenesis. J. Exp. Med. 2001, 193:621-630.
45. Hymowitz S.G., Christinger H.W., Fuh G., et al. Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol. Cell. 1999, 4:563-571.
46. Iizuka K., Chaplin D.D., Wang Y., et al. Requirement for membrane lymphotoxin in natural killer cell development. Proc. Natl Acad. Sci. USA 1999, 96:6336-6340.
47. Ito D., Back T.C., Shakhov A.N., et al. Mice with a targeted mutation in lymphotoxin-alpha exhibit enhanced tumor growth and metastasis: impaired NK cell development and recruitment. Immunology 1999, 163:2809-2815.
48. Jones E.Y., Stuart D.I., Walker N.P. Structure of tumour necrosis factor. Nature 1989, 338:225-228.
49. Kang H.S., Chin R.K., Wang Y., et al. Signaling via LTbetaR on the lamina propria stromal cells of the gut is required for IgA production. Nat. Immunol. 2002, 3:576-582.
50. Karpusas M., Hsu Y.M., Wang J.H., et al. 2 A crystal structure of an extracellular fragment of human CD40 ligand. Structure 1995, 3:1031-1039.
51. Kim D., Mebius R.E., MacMicking J.D., et al. Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE. J. Exp. Med. 2000, 192:1467-1478.
52. Koni P.A., Sacca R., Lawton P., et al. Distinct roles in lymphoid organogenesis for lymphotoxins α and β revealed in lymphotoxin β-deficient mice. Immunity 1997, 6:491-500.
53. Kontoyiannis D., Pasparakis M., Pizarro T.T., et al. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 1999, 10:387-398.
54. Kratz A., Campos-Neto A., Hanson M.S., Ruddle N.H. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J. Exp. Med. 1996, 183:1461-1472.
55. Kumaraguru U., Davis I.A., Deshpande S., et al. Lymphotoxin alpha(-/-) mice develop functionally impaired CD8(+) T cell responses and fail to contain virus infection of the central nervous system. J. Immunol. 2001, 166:1066-1074.
56. Lawton P., Nelson J., Tizard R., Browning J.L. Characterization of the mouse lymphotoxin-β gene. J. Immunol. 1995, 154:239-246.
57. Le Hir M., Bluethmann H., Kosco-Vilbois M.H., et al. Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling. J. Exp. Med. 1996, 183:2367-2372.
58. Lee B.J., Santee S., Von Gesjen S., et al. Lymphotoxin α -/- mice can clear a productive infection with murine gammaherpevirus-68 (MHV-68) but fail to develop splenomegaly or lymphocytosis. J. Virol. 2000, 74:2786-2792.
59. Lockesley R.M., Killeen N., Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001, 104:487-501.
60. Lu T.T., Cyster J.G. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 2002, 297:409-412.
61. Lucas R., Juillard P., Decoster E., et al. Crucial role of tumor necrosis factor (TNF) receptor 2 and membranebound TNF in experimental cerebral malaria. Eur. J. Immunol. 1997, 27:1719-1725.
62. Lucas R., Tacchini-Cottier F., Guler R., et al. A role for lymphotoxin β receptor in host defense against Mycobacterium bovis BCG infection. Eur. J. Immunol. 1999, 29:4002-4010.
63. Luther S.A., Lopez T., Bai W., et al. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 2000, 12:471-481.
64. Luther S.A., Bidgol A., Hargreaves D.C., et al. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 2002, 169:424-433.
65. MacEwan D.J. TNF receptor subtype signalling: differences and cellular consequences. Cell Signal. 2002, 14:477-492.
66. Mackay F., Browning J.L., Lawton P., et al. Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis. Gastroenterology 1998, 115:1464-1475.
67. Mariathasan S., Matsumoto M., Baranyay F., et al. Absence of lymph nodes in lymphotoxin-α (LT-α)-deficient mice is due to abnormal organ development, not defective lymphocyte migration. J. Inflammation 1995, 45:72-78.
68. Matsumoto M., Lo S.F., Carruthers C.J.L., et al. Affinity maturation without germinal centers in lymphotoxin-α-deficient mice. Nature 1996, 382:462-466.
69. Matsumoto M., Mariathasan S., Nahm M.H., et al. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science 1996, 271:1289-1291.
70. Mauri D.N., Ebner R., Montgomery R.I., et al. LIGHT, a new member of the TNF superfamily and lymphotoxin α are ligands for herpesvirus entry mediator. Immunity 1998, 8:21-30.
71. Mongkolsapaya J., Grimes J.M., Chen N., et al. Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation. Nat. Struct. Biol. 1999, 6:1048-1053.
72. Murphy M., Walter B.N., Pike-Noble L., et al. Expression of the lymphotoxin β-receptor on stromal dendritic cells in human lymphoid tissue. Cell Death Diff. 1998, 5:497-505.
73. Neumann B., Luz A., Pfeffer K., Holzmann B. Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor. J. Exp. Med. 1996, 184:259-264.
74. Ngo V.N., Cornall R.J., Cyster J.G. Splenic T zone development is B cell dependent. J. Exp. Med. 2001, 194:1649-1660.
75. Okada T., Ngo V.N., Ekland E.H., et al. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J. Exp. Med. 2002, 196:65-75.
76. Pasparakis M., Alexopoulou L., Episkopou V., Kollias G. Immune and inflammatory responses in TNFα-deficient mice: a critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 1996, 184:1397-1411.
77. Picarella D.E., Kratz A., Li C.B., et al. Insulitis in transgenic mice expressing tumor necrosis factor beta (lymphotoxin) in the pancreas. Proc. Natl. Acad. Sci. USA 1992, 89:10036-10040.
78. Puglielli M.T., Browning J.L., Brewer A.W., et al. Reversal of virus-induced systemic shock and respiratory failure by blockade of the lymphotoxin pathway. Nat. Med. 1999, 5:1370-1374.
79. Reif K., Ekland E.H., Ohl L., et al. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 2002, 416:94-99.
80. Rennert P.D., Browning J.L., Mebius R., et al. Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J. Exp. Med. 1996, 184:1999-2006.
81. Rennert P.D., James D., Mackay F., et al. Lymph node genesis is induced by signaling through the lymphotoxin beta receptor. Immunity 1998, 9:71-80.
82. Ruddle N.H., Waksman B.H. Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. I. Characterization of the phenomenon. J. Exp. Med. 1968, 128:1237-1254.
83. Ryffel B., di Padova F., Schreier M.H., et al. Lack of type 2 T cell-independent B cell responses and defect in isotype switching in TNF-Lymphotoxin α-deficient mice. J. Immunol. 1997, 158:2126-2133.
84. Scheu S., Alferink J., Potzel T., et al. Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis. J. Exp. Med. 2002, 195:1613-1624.
85. Shaikh R., Santee S., Granger S.W., et al. Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation and tissue destruction. J. Immunol. 2001, 167:6330-6337.
86. Shinkura R., Kitada K., Matsuda F., et al. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase. Nat. Genet. 1999, 22:74-77.
87. Smyth M.J., Johnstone R.W., Cretney E., et al. Multiple deficiencies underlie NK cell inactivity in lymphotoxinalphagene-targeted mice. J. Immunol. 1999, 163:1350-1353.
88. Spies T., Morton C.C., Nedospasov S.A., et al. Genes for the tumor necrosis factors α and β are linked to the human major histocompatibility complex. Proc. Natl. Acad. Sci. USA 1986, 83:8699-8702.
89. Tartaglia L.A., Ayres T.M., Wong G.H., Goeddel D.V. A novel domain with the 55 kd TNF receptor signals cell death. Cell 1993, 74:845-853.
90. Ueno T., Hara K., Willis M.S., et al. Role for CCR7 ligands in the emigration of newly generated T lymphocytes from the neonatal thymus. Immunity 2002, 16:205-218.
91. VanArsdale T.L., VanArsdale S.L., Force W.R., et al. Lymphotoxin-β receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor βB. Proc. Natl Acad. Sci. USA 1997, 94:2460-2465.
92. Wallach D., Varfolomeev E.E., Malinin N.L., et al. Tumor necrosis factor receptor and Fas signaling mechanisms. Ann. Rev. Immunol. 1999, 17:331-367.
93. Ware C.F., Ruddle N. Lymphotoxin α and β. Cytokine Database 1999, Academic Press, San Diego.
94. Ware C.F., Harris P.C., Granger G.A. Mechanisms of lymphocyte-mediated cytotoxicity. II. Biochemical and serologic identification of a precursor lymphotoxin form (pre-LT) produced by MLC-sensitized human T lymphocytes in vitro. J. Immunol. 1981, 126:1927-1933.
95. Ware C.F., Crowe P.D., VanArsdale T.L., et al. Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells. J. Immunol. 1991, 147:4229-4238.
96. Ware C.F., Crowe P.D., Grayson M.H., et al. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. J. Immunol. 1992, 149:3881-3888.
97. Ware C.F., VanArsdale T.L., Crowe P.D., Browning J.L. The ligands and receptors of the lymphotoxin system. Pathways for Cytolysis 1995, 175-218. Springer-Verlag, Basel. G.M. Griffiths, J. Tschopp (Eds.).
98. Ware C.F., Santee S., Glass A. Tumor necrosis factor-related ligands and receptors. The Cytokine Handbook 1998, 549-592. Academic Press, San Diego. 3rd edn. A. Thompson (Ed.).
99. Williams-Abbott L., Walter B.N., Cheung T., et al. The lymphotoxin-α (LTα) subunit is essential for the assembly, but not receptor specificity, of the membrane-anchored LTαβ2 heterotrimeric ligand. J. Biol. Chem. 1997, 272:19451-19456.
100. Wu Q., Sun Y., Wang J., et al. Signal via lymphotoxin-beta receptor on bone marrow stromal cells is required for an early chekpoint of NK cell development. J. Immunol. 2001, 166:1684-1689.
101. Yin L., Wu L., Wesche H., et al. Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. Science 2001, 291:2162-2165.
102. Yoshida H., Kawamoto H., Santee S.M., et al. Expression of alpha(4)beta(7) integrin defines a distinct pathway of lymphoid progenitors committed to T cells, fetal intestinal lymphotoxin producer, NK, and dendritic cells. J. Immunol. 2001, 167:2511-2521.
103. Yu P., Wang Y., Chin R.K., et al. B cells control the migration of a subset of dendritic cells into B cell follicles via CXC chemokine ligand 13 in a lymphotoxin-dependent fashion. J. Immunol. 2002, 168:5117-5123.